Methanesulfonyl chloride → Benzyl 4-(((methylsulfonyl)oxy)methyl)piperidine-1-carboxylate

HRID 1290503

Reaktionsgleichung

[CH3:1][S:2](Cl)(=[O:4])=[O:3].[CH2:6]([O:13][C:14]([N:16]1[CH2:21][CH2:20][CH:19]([CH2:22][OH:23])[CH2:18][CH2:17]1)=[O:15])[C:7]1[CH:12]=[CH:11][CH:10]=[CH:9][CH:8]=1>ClCCl>[CH2:6]([O:13][C:14]([N:16]1[CH2:21][CH2:20][CH:19]([CH2:22][O:23][S:2]([CH3:1])(=[O:4])=[O:3])[CH2:18][CH2:17]1)=[O:15])[C:7]1[CH:12]=[CH:11][CH:10]=[CH:9][CH:8]=1

Komponenten

Reaktionsbedingungen

Temperatur: 5 °C

Versuchsvorschrift

A solution of methanesulphonylchloride (7.7 ml) in dichloromethane (50 ml) was added dropwise to a stirred solution of 1-benzyloxycarbonyl-4-hydroxymethylpiperidine (23.4 g) in dichloromethane (350 ml) cooled to 5° C. Stirring was continued for 1 hour, then the solution was washed with water (4×150 ml) and saturated aqueous sodium chloride (100 ml), dried and concentrated. The residue was crystallised from tetrachloromethane (250 ml) to give 1-benzyloxycarbonyl-4-methanesulphonyloxymethylpiperidine (20 g) as colourless prisms, m.p. 72°-74° C. NMR (CDCl3) δ1.1-1.4(2H,m); 1.7-1.8(2H,d); 1.9-2.1(1H,m); 2.7-2.9(2H,t); 3.0(3H,s); 4.05(2H,d); 4.1-4.4(2H,d); 5.1(2H,s); 7.3(5H,m); m/e 328(M+H)+350 (M+Na)+ ; calculated for C15H21N5 O5 : C, 55.0;H, 6.5; N, 4.3; found: C, 54.8; H, 6.6; N, 4.2%.

Aufarbeitung

washthe solution was washed with water (4×150 ml) and saturated aqueous sodium chloride (100 ml)
customdried
concentrationconcentrated
customThe residue was crystallised from tetrachloromethane (250 ml)

Quellen und Nachweise

ORD-Eintrag: ord-fa9532b7c37c4a5a937529402cbe23ed
Quelldatensatz: uspto-grants-1998_05
DOI: 10.6084/m9.figshare.5104873.v1
Patentnummer: US05750754

Verknüpfte Notizen

Wird geladen…